Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

TECAN GROUP LTD.

Tecan is a provider of automated laboratory instruments and solutions for people working in clinical diagnostics, bas... read more Featured Products: More products

Download Mobile App




Two Chikungunya Virus IgM Enzyme-Linked Immunoassays Evaluated

By LabMedica International staff writers
Posted on 11 Feb 2020
Chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes (Stegomyia) spp. More...
mosquitoes. Transmission was initially restricted to small outbreaks and sporadic cases in Africa and Asia, but since early 2000s the virus has caused large outbreaks in India and Southeast Asia.

Acute clinical manifestations associated with CHIKV infections are non-specific, usually including fever, rash, and arthralgia, the latter being the most prominent symptom that may last for months or years, causing chronic disabilities. In areas where other arboviruses with similar clinical manifestations co-circulate laboratory diagnostic tools that distinguish CHIKV infections from them are urgently needed.

Scientists from the Fundação Oswaldo Cruz (Salvador, Brazil) enrolled 372 patients attending a public emergency health unit in an acute febrile illness (AFI) enhanced surveillance study and blood samples were drawn for arboviral diagnosis. All acute-phase sera, which had not been previously thawed, were submitted to RNA extraction and tested by reverse-transcription polymerase chain reaction (RT-PCR) for Dengue (DENV), Zika (ZIKV), and CHIKV.

The team tested the acute- and paired convalescent-phase sera available from all the CHIKV, DENV, and ZIKV RT-PCR-positive patients enrolled during surveillance with both the CHIKjj Detect IgM-capture ELISA kit (Inbios International, Inc., Seattle, WA, USA) and the Anti-Chikungunya virus ELISA (IgM) Test (Euroimmun, Luebeck, Germany). They also applied the Inbios and the Euroimmun CHIKV IgM ELISA tests to the acute- and paired convalescent-phase sera from 175 patients randomly selected from those with negative RT-PCR results (for all three arboviruses) and with paired sera available. The ELISA reading was performed by automated microplate reader at 450 nm (TECAN, Männedorf, Switzerland).

The scientists reported that the Inbios and Euroimmun tests’ sensitivities for acute samples were 4.0% and 10.3%, while for convalescent samples they were 92.4% and 96.9%, respectively. Overall, Inbios IgM ELISA specificities for acute and convalescent samples were 97.7% and 90.5%, respectively, and Euroimmun specificities were 88.5% and 83.9%, respectively.

The authors concluded that both tests presented high sensitivity for convalescent samples. However, the Euroimmun test returned more equivocal results and presented a slightly lower specificity, which might result in a higher rate of false positives if the test is used in scenarios of low CHIKV transmission, when the chance of CHIKV infection is lower. The study was published in the February, 2020 issue of International Journal of Infectious Diseases.


Related Links:
Fundação Oswaldo Cruz
Inbios International
Euroimmun
TECAN



New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hybrid Pipette
SWITCH
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.